New drug treatment for Parkinson's disease
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2006 |
|---|---|
| Erschienen: |
2006 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
FDA consumer - 40(2006), 4 vom: 20. Juli, Seite 7 |
| Sprache: |
Englisch |
|---|
| Themen: |
003N66TS6T |
|---|
| Anmerkungen: |
Date Completed 24.01.2007 Date Revised 15.11.2012 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM167905996 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM167905996 | ||
| 003 | DE-627 | ||
| 005 | 20231223113951.0 | ||
| 007 | tu | ||
| 008 | 231223s2006 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0560.xml |
| 035 | |a (DE-627)NLM167905996 | ||
| 035 | |a (NLM)17245831 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a New drug treatment for Parkinson's disease |
| 264 | 1 | |c 2006 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 24.01.2007 | ||
| 500 | |a Date Revised 15.11.2012 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a News | |
| 650 | 7 | |a Indans |2 NLM | |
| 650 | 7 | |a Monoamine Oxidase Inhibitors |2 NLM | |
| 650 | 7 | |a Neuroprotective Agents |2 NLM | |
| 650 | 7 | |a rasagiline |2 NLM | |
| 650 | 7 | |a 003N66TS6T |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t FDA consumer |d 1974 |g 40(2006), 4 vom: 20. Juli, Seite 7 |w (DE-627)NLM008100454 |x 0362-1332 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2006 |g number:4 |g day:20 |g month:07 |g pages:7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2006 |e 4 |b 20 |c 07 |h 7 | ||